Arbor Biotechnologies logo

Arbor Biotechnologies Funding & Investors

Arbor Biotechnologies operator of a bio-discovery company intended to provide human diagnostic development service. The company's platform employs a diverse set of technologies and techniques including artificial intelligence, genome sequencing, gene synthesis and high-throughput screening, enabling drug developers to accelerate the discovery of proteins for improving human health and sustainability.

arbor.bio

Total Amount Raised: $230,600,000

Arbor Biotechnologies Funding Rounds

  • Series B

    $215,000,000

    Series B Investors

    Illumina Ventures
    Tao Capital Partners
    GreatPoint Ventures
    Logos Capital Management
    Woodline Partners
    Ono Venture Investment
    Tekla Capital Management
    Arch Venture Partners
    ArrowMark Partners
    Piper Sandler
    Vertex Pharmaceuticals
    Surveyor Capital
    Ridgeback Capital Management
    Ally Bridge Group
    Temasek
    Section 32
    Henderson Global Investors
    TCGX
    T. Rowe Price
    Deep Track Capital
  • Series A

    $15,600,000

    Series A Investors

    Arch Venture Partners
    Alexandria Real Estate Equities
Funding info provided by Diffbot.